Moreover, there is evidence to suggest that circulating IL-33 may confer protective metabolic effects in humans, more specifically, in individuals with normal weight and glycemia but not with obesity and/or T2D [54]. The gene discussed is IL33; the disease is type 2 diabetes mellitus.